期刊文献+

帕珠沙星对呼吸道和泌尿道感染常见病原菌的体外抗菌活性研究

Antibacterial activity of pazufloxacin to respiratory and urinary tract infectious pathogens in vitro
下载PDF
导出
摘要 目的:了解帕珠沙星对呼吸道和泌尿道感染常见病原菌的体外抗菌活性,指导临床合理用药。方法:常规分离培养细菌,用VITEKⅡ全自动细菌鉴定分析仪鉴定到种。药敏试验用琼脂平板稀释法检测MIC。结果:帕珠沙星对大肠埃希菌、嗜血杆菌、表皮葡萄球菌、肺炎克雷伯菌、粪肠球菌的抑菌率分别为87.2%、100%、100%、75.0%、85.7%、100%,总的抑菌率为88.8%。结论:帕珠沙星是一种有效的广谱抗菌物质,对呼吸道和泌尿道感染常见病原菌有较强的抗菌活性,可以作为治疗呼吸道和泌尿道感染的一线药物。 Objective:To investigate the antibacterial activity of pazufloxacin to respiratory and urinary tract infectious pathogens and provide the data of rational use of antibiotic substance. Methods: The samples of sputum, urine and prostatic fluid of the patients with respiratory or urinary tract infectious diseases were screened. The bacteria in these samples were cultured and identified by VITEK Ⅱ automicrobic system. The minimal inhibitory concentration(MIC) of pazufloxacin was measured with agar dilution method. Results: Inhibitory rates of pazufloxacin to Escherichia coli, Haemophilus, Staphylococcus epidermidis, Klebsiella pneumonia and Enterococcus faecalis were 87. 20%, 100%, 100%, 75.0%, 85. 7% and 100%, respectively. The total inhibitory rate was 88. 80%. Conclusion, Pazufloxacin is an effective broad - spectrum antibacterial agent. It has strong activity to common pathogens in respiratory and urinary tracts and may be used as the first line drug for respiratory and urinary tract infection.
出处 《西南国防医药》 CAS 2008年第3期344-345,共2页 Medical Journal of National Defending Forces in Southwest China
关键词 帕珠沙星 抗菌活性 呼吸道感染 泌尿道感染 pazufloxacin minimal inhibitory concentration respiratory infection urinary tract infection
  • 相关文献

参考文献5

二级参考文献22

  • 1Totsuka, Kyoichi. in vitro and in vivo post antibiotic effects of pazufloxacin [J]. a new synthetic antimicrobial agent, 1995;43(Suppl.2): 34.
  • 2Ohmichi,Mitsuhide. et al. In vitro antibacterial activity and pharmacokinetics of pazufloxacin mesilate and its clinical efficacy in respiratory tract infection[J]. Nippon Kagaku Ryoho Gakkai Zasshi 1999; 47(Suppl.1):196.
  • 3Goto,Hirokazu et al. Fundamental and clinical studies of pazufloxacin in urinary and genital infections [J]. Nippon Kagaku Ryoho Gakkai Zasshi, 1995 ;43(Suppl.2):324.
  • 4Nishino T,Ikeda Y,Otsuki M,et al.In vitro and in vivo antibacterial activity of pazufloxacin mesilate,a new parenteral fluroquinolone[J].Jpn J Chemother(日文),1999,47(S-1):S25-S36.
  • 5Mitsuyama J,Miyazaki S,Ishii Y,et al.Antibacterial activity of a new injectable quinolone pazufloxacin mesilate in vitro and in vivo[J].Jpn J Chemother(日文),1999,47(S-1):S1-S15.
  • 6Mitsuyama J,Takahata M,Yamashiro Y,et al.Antibacterial activity of a new injectable quinolone,pazufloxacin mesilate,in vitro and in vivo[J].Jpn J Chemother(日文),1999,47(S-1):S37-S64.
  • 7Nakata M,Yamashiro Y,Shimakura M,et al.Pharmacokinetics of pazufloxacin mesilate in experimental animals[J].Jpn J Chemother(日文),1999,47(S-1):S65-S74.
  • 8Nakashima M,Uemura K,Kosuge K,et al.Phase I clinical study of pazufloxacin mesilate[J].Jpn J Chemother(日文),1999,47(S-1):S141-S175.
  • 9Takagi K,Yajima Y,Yoshizawa H.Pharmacokinetics of pazufloxacin mesilate in elderly subjects[J].Jpn J Chemother(日文),2000,48(8):633-644.
  • 10Aoki N,Usuda Y,Isizuka Y,et al.Pharmacokinetics of pazufloxacin mesilate in the elderly[J].Jpn J Chemother(日文),1999,47(S-1):S204-S208.

共引文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部